Cargando…
The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival
The PvuII (rs2234693) Single Nucleotide Polymorphism (SNP) in the gene coding for the estrogen receptor-1 (ESR1), has been found associated with outcome in tamoxifen treated patients with early hormone-receptor positive breast cancer. However, it remains unclear whether this SNP is a predictive mark...
Autores principales: | Houtsma, Danny, de Groot, Stefanie, Baak-Pablo, Renee, Kranenbarg, Elma Meershoek -Klein, Seynaeve, Caroline M., van de Velde, Cornelis J. H., Böhringer, Stefan, Kroep, Judith R., Guchelaar, Henk -Jan, Gelderblom, Hans |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864972/ https://www.ncbi.nlm.nih.gov/pubmed/33547330 http://dx.doi.org/10.1038/s41598-021-82002-z |
Ejemplares similares
-
ESR1 PvuII (rs2234693 T>C) polymorphism and cancer susceptibility: Evidence from 80 studies
por: Liu, Xiaoqi, et al.
Publicado: (2018) -
PvuII polymorphism of estrogen receptor-α gene in breast cancer
por: Surekha, D., et al.
Publicado: (2007) -
TALE-PvuII Fusion Proteins – Novel Tools for Gene Targeting
por: Yanik, Mert, et al.
Publicado: (2013) -
Polymorphism of PvuII, Xba1, and SNP 12 Estrogen Receptor 1 (ESR1) in Hipospadias Patients at Tertiary Hospital Center
por: Siregar, Safendra, et al.
Publicado: (2021) -
Association Between ESR1 PvuII, XbaI, and P325P Polymorphisms and Breast Cancer Susceptibility: A Meta-Analysis
por: Zhang, Yiming, et al.
Publicado: (2015)